Galantamine shows sustained cognitive benefits in patients with Alzheimer's disease (AD)

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1430, 2004-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Statins on Cognitive Function in Patients with Alzheimer's Disease in Galantamine Clinical Trials

By Winblad Bengt

Drugs & Aging, Vol. 24, Iss. 1, 2007-01 ,pp. : 57-61

Adis International

Access to resources Recommend Favorite

Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimers Disease with Cerebrovascular Disease

By Small G.

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 905-914

Adis International

Access to resources Recommend Favorite

Cognitive enhancers provide some benefits in patients with moderate to severe Alzheimer's disease

Drugs & Therapy Perspectives, Vol. 27, Iss. 4, 2011-04 ,pp. : 9-15

Adis International

Access to resources Recommend Favorite

Galantamine for Alzheimer's disease

By Prvulovic David Hampel Harald Pantel Johannes

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite

A Naturalistic Study of Galantamine for Alzheimer's Disease

By Brodaty Henry

CNS Drugs, Vol. 20, Iss. 11, 2006-01 ,pp. : 935-943

Adis International

Access to resources Recommend Favorite